Welcome message from local president

President
	Kiyohiko Hatake Professor, Department of Hematology, International University of Health and Welfare, School of Medicine Cancer Chemotherapy Center, Japanese Foundation for Cancer Research
Co-presidents
	David Khayat Medical Oncology Department, Clinique BIZET
	Gabriel Hortobagyi Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center

Welcome to Tokyo, Japan.

May is a good season to visit Japan.  We are very happy to announce that we are going to hold a meeting of Anti-Cancer Treatment Japan.  As you know, Professor David Khayat and Professor Gabriel Hortobagyi invited me several times to Paris to attend ICACT for several years.  We enjoyed it very much and two of them suggested me to have a meeting in Japan.  As a local president, with co-presidents, David and Gab, we are preparing and organizing education meeting in Tokyo.

Mission:  To learn every kind of anti-cancer treatment, special attention to manage the adverse events, including conventional chemotherapy, high dose chemo, molecular targeting drug, immune check point inhibitors.  These sessions are very educational, by international experts and communicable. 
This time we will focus on the topics of new cancer treatment and adverse event management. 

Organ specific sessions:  Breast cancer, lung cancer, GI, hepatobiliary-pancreatic, urological, gynecological, hematological, basic, including CTC, biomarker, and immune check point inhibition.

Educational oral and poster presentations for participants: International experts will give lectures in English, and the participants will present as poster sessions. 

Theme: Manage the adverse events better and improve the quality of anti-cancer treatment.

Lean objectives:  Younger investigators will be able to learn education sessions by international experts.